Women's health
Ganirelix
Gonadotropin Releasing Hormone (GnRH) Antagonist
Other names: Antagon, Fyremadel
Wait
7 days
after the first dose
Different waits apply in other cases.
The FAA's MedGuide lists ganirelix (Antagon, Fyremadel) as allowed, for infertility or in-vitro fertilization (IVF), with a wait of 7 days after the first dose and 4 hours after each dose and the same after the final dose, used as prescribed.
Track your medicationsMore detail: ganirelixThe rest of Crosscheck's reading, in plain wordsOpen
Wait
- 4 hours after each dose
- 4 hours after the final dose
The MedGuide defines allowed as acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present, and says wait times are not determined solely by the medication: an extended observation period may be required to verify clinical stability of the condition.
- 7 days after the first dose: ground observation
- 4 hours after each dose: ground observation
- 4 hours after stopping: ground observation
Show the FAA's words: ganirelixThe official FAA wording: three passages, each with its document and dateOpen
Generic: ganirelix
Brand Name: Antagon; Fyremadel
Drug Class: Gonadotropin Releasing Hormone (GnRH) Antagonist
Underlying Condition: Infertility; In-vitro fertilization (IVF)
Use: ALLOW
INITIAL Wait Time (after first dose): 7 days
SUBSEQUENT Dose Wait Time (after each dose): 4 hours
DISCONTINUATION Wait Time (after final dose): Same as subsequent dose wait time
Frequency Use Limit: As prescribed
ALLOWED: The medication is acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present.
Underlying Condition: Evaluating medication use requires considering the impact of safety of flight from both the medication and underlying condition. Wait times are not determined solely by the medication; an extended observation period may be required to verify clinical stability of the condition.